Formulations of pyrimidine cyclohexyl glucocorticoid receptor modulators

A composition comprising:

• Compound I, (E)-6-(4-Phenylcyclohexyl)-5-(3-trifluoromethylbenzyl)-1H-pyrimidine-2,4-dione:
• in an amount from 15.0 to 32.0% (w/w);
• a poly[(methyl methacrylate)-co-(methacrylic acid)] in an amount from 15.0 to 32.0% (w/w);
• a sustaining polymer in an amount from 10.0 to 32.0% (w/w);
• microcrystalline cellulose in an amount from 10.0 to 25.0% (w/w);
• and
• croscarmellose sodium (Ac-Di-Sol) in an amount from 5.0 to 11.0% (w/w).